BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...Corp., which was acquired in 2008 by Vifor Pharma Ltd. (SIX:VIFN) for about $915 million; NeuroVir Therapeutics Inc....
BioCentury | May 14, 2012
Strategy

Teva: No more silos

...He is board certified in internal medicine and medical genetics. He founded gene therapy company NeuroVir...
BioCentury | May 9, 2012
Company News

Teva names Hayden CSO

...Research Chair in Human Genetics and Molecular Medicine. He has founded three biotechs: cancer company NeuroVir...
BioCentury | Sep 11, 2006
Strategy

Biotech accumulators

...clinic have come from the herpes simplex virus platform that MDG obtained when it acquired NeuroVir Therapeutics Inc....
BioCentury | Sep 11, 2006
Strategy

MediGene chronicles

...Acquires the 91% of NeuroVir it doesn’t already own for about E53M ($50M) in stock. NeuroVir...
BioCentury | Sep 22, 2003
Company News

Oncolytics scientific advisory board update

...Tuchman, clinical professor of neurology at New York Medical College; and Frank Tufaro, founder of Neurovir...
BioCentury | Sep 10, 2001
Company News

MediGene, Children's Hospital deal

...outside its focus, such as Huntington's disease. The license originally was between the hospital and NeuroVir Therapeutics Inc....
BioCentury | Sep 6, 2001
Company News

MediGene expands amplicon license

...outside its focus, such as Huntington's disease. The license originally was between the Hospital and NeuroVir...
BioCentury | Apr 9, 2001
Company News

Cell Genesys management update

...Ostrove as president and COO of CEGE's Ceregene Inc. majority owned subsidiary, formerly COO at NeuroVir Therapeutics Inc. WIR...
BioCentury | Mar 12, 2001
Clinical News

G207 engineered herpes simplex virus: Phase I

...G207 were still alive two years after treatment. MDG, which received G207 when it acquired NeuroVir Therapeutics Inc....
Items per page:
1 - 10 of 27
BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...Corp., which was acquired in 2008 by Vifor Pharma Ltd. (SIX:VIFN) for about $915 million; NeuroVir Therapeutics Inc....
BioCentury | May 14, 2012
Strategy

Teva: No more silos

...He is board certified in internal medicine and medical genetics. He founded gene therapy company NeuroVir...
BioCentury | May 9, 2012
Company News

Teva names Hayden CSO

...Research Chair in Human Genetics and Molecular Medicine. He has founded three biotechs: cancer company NeuroVir...
BioCentury | Sep 11, 2006
Strategy

Biotech accumulators

...clinic have come from the herpes simplex virus platform that MDG obtained when it acquired NeuroVir Therapeutics Inc....
BioCentury | Sep 11, 2006
Strategy

MediGene chronicles

...Acquires the 91% of NeuroVir it doesn’t already own for about E53M ($50M) in stock. NeuroVir...
BioCentury | Sep 22, 2003
Company News

Oncolytics scientific advisory board update

...Tuchman, clinical professor of neurology at New York Medical College; and Frank Tufaro, founder of Neurovir...
BioCentury | Sep 10, 2001
Company News

MediGene, Children's Hospital deal

...outside its focus, such as Huntington's disease. The license originally was between the hospital and NeuroVir Therapeutics Inc....
BioCentury | Sep 6, 2001
Company News

MediGene expands amplicon license

...outside its focus, such as Huntington's disease. The license originally was between the Hospital and NeuroVir...
BioCentury | Apr 9, 2001
Company News

Cell Genesys management update

...Ostrove as president and COO of CEGE's Ceregene Inc. majority owned subsidiary, formerly COO at NeuroVir Therapeutics Inc. WIR...
BioCentury | Mar 12, 2001
Clinical News

G207 engineered herpes simplex virus: Phase I

...G207 were still alive two years after treatment. MDG, which received G207 when it acquired NeuroVir Therapeutics Inc....
Items per page:
1 - 10 of 27